Sino Biopharmaceutical Limited (SBMFF) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.44 | 1.19 | 1.17 | 0.37 | 1.18 | -1.37 | ||
| Changes by years, y/y, % | -81% | +168% | -1% | -68% | +218% | -12.6% | |||
Sino Biopharmaceutical Limited. EV/EBITDA
Sino Biopharmaceutical Limited. EV/EBITDA, changes, %
Sino Biopharmaceutical Limited (SBMFF) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 0.48 | 0.37 | 0.05 | 0.76 | -1.13 | -1.37 | |
| Changes by years, y/y, % | -307% | -254% | -110% | +104% | -404% | |||
| Changes by quarters, q/q, % | +29% | -23% | -86% | +1 366% | -249% | |||